Developer of portable MRI and Robotic platform, neuro42 secures investment
Singapore, May 2 -- In a recent announcement, US-based medtech startup neuro42 has secured undisclosed investments from investor, Karna D Shinde. This is Karna's third round of investment in the company. neuro42, a game changer technology in the field of neurosurgery recently received US FDA clearance for its innovative diagnostic MRI product. The 510(k) clearance, received in February 2024, marks a significant milestone for neuro42 and sets the stage for the commercialisation of its cutting-edge diagnostic MRI machine later this year.
neuro42's portable MRI is designed to specialise in imaging the brain and head, with a key focus on MR-guided interventions. One of the primary drivers of innovation at neuro42 is its ability to amplify th...
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.